PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDO L-5-YL)PYRAZOLE-4-CARBOXYLIC ACID

The present invention relates to: a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid, or a pharmaceutically acceptable salt thereof; and a method for preventing or treating hyperuricemia-related diseases using same. The pharmaceutical composition acc...

Full description

Saved in:
Bibliographic Details
Main Authors GWAK Heemin, SEO Jung Youn, LEE Jieun, SHIN Seong Hye, KIM Min Hee, KIM Junyu, MIN Ji Young, MUNE June Sik
Format Patent
LanguageEnglish
Spanish
Published 15.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to: a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid, or a pharmaceutically acceptable salt thereof; and a method for preventing or treating hyperuricemia-related diseases using same. The pharmaceutical composition according to the present invention can effectively reduce the blood uric acid concentration of a patient with a hyperuricemia-related disease. La presente invención se refiere a una composición farmacéutica que comprende ácido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-ca rboxílico o una sal farmacéuticamente aceptable de este, y un método para tratar o prevenir una enfermedad relacionada con la hiperuricemia usándolo, y la composición farmacéutica de la presente invención puede reducir de manera eficaz la concentración de ácido úrico en sangre en un paciente con una enfermedad relacionada con la hiperuricemia.
Bibliography:Application Number: MX20230014359